← Clinical Evidence

SRC-9935c024926a Qaisar R 2026

Evidence source and scope

Plasma CAF22 Predicts Incident Freezing of Gait in Parkinson's Disease: A Prospective Cohort Study.

This note indexes a cited or audit-added source. It may be an original study, review, guideline, form or methods reference. Treat the specific design and the evidence below as authoritative; a source note is not automatically a primary study.

DOI: 10.1007/s12031-026-02584-z

Bibliographic record from the original reports

Access labels embedded in these original reference strings are historical. Current access and exact checked components are stated separately below.

Qaisar R, Iqbal MS, Karim A, Ahmad F. Plasma CAF22 Predicts Incident Freezing of Gait in Parkinson's Disease: A Prospective Cohort Study. J Mol Neurosci. 2026;76(3):126. DOI 10.1007/s12031-026-02584-z

Conditions: COND-PD Parkinson’s disease

Scoped audit evidence

These are source- and component-level audit summaries as of 3 October 2026. Access and comparison scope can differ by report; none certifies every result or the underlying raw data.

Parkinson’s disease — strength

STR-70-01

Limitations: Only current scoped checks; archived captures not authenticated against live originals.

Parkinson’s disease strength

Parkinson’s disease strength component — CAF22 study does not report a strength effect in abstract

The abstract matches 233 PD participants without freezing, 24-month follow-up and 55 events. Strength is a covariate; reported independent coefficients concern CAF 22 and gait. No independent strength coefficient is supplied.

Source locator: Primary abstract

Limitations: AI-assisted source comparison; no raw-data verification.

Reports citing this source

Update record

Updating the wiki · Evidence and status guide